No Data
No Data
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. From The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended on March 18,
Express News | NeuBase Therapeutics - Expects Trading in Co's Common Stock Will Be Suspended Upon Opening of Business on May 13
Express News | NeuBase Therapeutics Inc - on May 2, Nasdaq Notified Company That It Has Not Regained Compliance With Minimum Bid Price Requirement
NeuBase Therapeutics Announces Receipt of Notice From Nasdaq
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday's session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13
VERI, CHEK and CZOO Among Mid-day Movers
No Data